Nonleg venous thrombosis in critically Ill adults a nested prospective cohort study
Nonleg venous thrombosis in critically Ill adults a nested prospective cohort study
Importance Critically ill patients are at risk of venous thrombosis, and therefore guidelines recommend daily thromboprophylaxis. Deep vein thrombosis (DVT) commonly occurs in the lower extremities but can occur in other sites including the head and neck, trunk, and upper extremities. The risk of nonleg deep venous thromboses (NLDVTs), predisposing factors, and the association between NLDVTs and pulmonary embolism (PE) or death are unclear.
Objective To describe the frequency, anatomical location, risk factors, management, and consequences of NLDVTs in a large cohort of medical-surgical critically ill adults.
Design, Setting, and Participants A nested prospective cohort study in the setting of secondary and tertiary care intensive care units (ICUs). The study population comprised 3746 patients, who were expected to remain in the ICU for at least 3 days and were enrolled in a randomized clinical trial of dalteparin vs standard heparin for thromboprophylaxis.
Main Outcomes and Measures The proportion of patients who had NLDVTs, the mean number per patient, and the anatomical location. We characterized NLDVTs as prevalent or incident (identified within 72 hours of ICU admission or thereafter) and whether they were catheter related or not. We used multivariable regression models to evaluate risk factors for NLDVT and to examine subsequent anticoagulant therapy, associated PE, and death.
Results Of 3746 trial patients, 84 (2.2%) developed 1 or more non–leg vein thromboses (superficial or deep, proximal or distal). Thromboses were more commonly incident (n = 75 [2.0%]) than prevalent (n = 9 [0.2%]) (P < .001) and more often deep (n = 67 [1.8%]) than superficial (n = 31 [0.8%]) (P < .001). Cancer was the only independent predictor of incident NLDVT (hazard ratio [HR], 2.22; 95% CI, 1.06-4.65). After adjusting for Acute Physiology and Chronic Health Evaluation (APACHE) II scores, personal or family history of venous thromboembolism, body mass index, vasopressor use, type of thromboprophylaxis, and presence of leg DVT, NLDVTs were associated with an increased risk of PE (HR, 11.83; 95% CI, 4.80-29.18). Nonleg DVTs were not associated with ICU mortality (HR, 1.09; 95% CI, 0.62-1.92) in a model adjusting for age, APACHE II, vasopressor use, mechanical ventilation, renal replacement therapy, and platelet count below 50 × 109/L.
Conclusions and Relevance Despite universal heparin thromboprophylaxis, nonleg thromboses are found in 2.2% of medical-surgical critically ill patients, primarily in deep veins and proximal veins. Patients who have a malignant condition may have a significantly higher risk of developing NLDVT, and patients with NLDVT, compared with those without, appeared to be at higher risk of PE but not higher risk of death.
Trial Registration clinicaltrials.gov Identifier: NCT00182143
689-696
Lamontagne, F.
4d84ce8c-0368-40e2-83f9-8488899e9241
McIntyre, L.
fba00f27-7b8b-42cf-89c0-62ad002221cc
Dodek, P.
ee29f74b-3884-4c96-9980-c7b0b377fafd
Heels-Ansdell, D.
364ac741-2508-44ca-875a-26fa5b7f5833
Meade, M.
157e7055-92ac-4c89-ab51-3e9039b0d904
Pemberton, J.
91d4d2f9-901b-4fe6-bbf1-a303d9032828
Skrobik, Y.
68cf8f4a-0336-4c99-86c7-b62363c2f82d
Seppelt, I.
27d38f50-c9fc-4d5c-bec1-45e69b6d3604
Vlahakis, N.E.
371da7ba-1ea8-48b7-ae16-5d63dd04b05a
Muscedere, J.
949ec41b-09d5-4b1a-9a9f-b726c8ff530b
Reece, G.
27d44934-027f-406b-bbf2-841483f085ec
Ostermann, M.
3aad45dd-7d86-40cf-80ee-d6401ebdace2
Padayachee, S.
44487cf9-1d7b-4fe1-a69c-177d1e29ceea
Alhashemi, J.
56fd0c9f-1d57-43c7-9237-75879f17fee3
Walsh, M.
af03f6c9-6790-4d20-b1eb-7e89eb7f8d13
Lewis, B.
e6341bc4-ae2e-4678-8cf8-f1237f740cf9
Schiff, D.
74d7510e-affe-4fea-b4a8-83da6b6eced5
Moody, A.
92e46e31-f39f-45cc-9f83-d13fb1de620a
Zytaruk, N.
ff2a88e5-6d8f-4c40-b42c-3b599903b604
LeBlanc, M.
ac6c8255-f84b-4408-8f4a-66c26e395019
Cook, D.J.
611a8241-6755-4977-956a-cabbff5373d3
Lesur, O.
962c34f7-d58f-46da-8018-e958dcfd4c83
Proulx, S.
2b5af2a1-1f08-445b-a255-dbbed0c9150f
Cloutier, S.
0b87abd8-6944-4d9c-aaf4-4b2b82947740
Bolduc, B.
20ec53e4-73fb-4f50-a8cc-235ddcbe3951
Rousseau, M.-P.
7064e98c-f7e4-4182-b46a-db5863a8252e
Leblond, J.
62ab95bb-5f7b-4300-96b1-314d9e7dd599
Schmutz, G.
5843bc75-938d-4aba-88f7-c4b6d4fb4b18
Hebert, P.
db06cda1-bea6-4a97-8cd7-52db87b22a6f
Watpool, I.
72327c18-076d-4412-92cd-b82f17e909e4
McArdle, T.
bd4294df-f458-4de1-aa86-b5986f8da16c
Gaudert, C.
28df7bc6-28e3-47fe-b0ca-574511566754
Marchand, P.
5c97eec8-1089-49cb-b825-875de03af64b
Davidson, C.
1d26c907-6221-4335-9c15-acd5862bf0d8
Dugal, A.-M.
1051086f-4a13-47a6-bf64-96c1b6d1038d
Fetzer, S.
6979fca9-4ca5-4c81-8c9f-7de10fc71eef
Shabana, W.
134eb791-7f69-403a-9197-2234f4cea515
Castonguay, M.
f83c0983-7ea9-476f-8660-4682eea05744
Anwar, S.
0c78bee7-b0f4-4e55-874e-68543690362a
Kozarenko, V.
19365d3a-d435-4a40-abf3-7bc50e5b5c2b
Mohammad, S.
641b37f7-4100-471d-8c34-c600299520a7
Sikalska, S.
f761834d-2bd8-4239-95e5-d7b7a2fba02f
Gauthier, S.
1b315d1d-07f0-4ac4-9658-0740bcd7fc19
Mustafa, A.
f362a6d6-291f-477c-9e5c-78fc879693ed
Ashley, B.J.
83b23372-4fee-4bdb-b0da-c3e72565138f
Mans, S.
9ee436d2-45b3-457f-ae11-9f13a4e99a36
Pavan, M.
f4896fdf-4860-4e5a-b066-6dd98bd427d9
Leipsic, J.
24a7559b-a517-44e5-8b39-157ade85f8b3
Meiersdorf, S.
112a83bd-c87d-411c-8a6e-118a3baca378
McKenzie, C.
ec344dee-5777-49c5-970e-6326e82c9f8c
2014
Lamontagne, F.
4d84ce8c-0368-40e2-83f9-8488899e9241
McIntyre, L.
fba00f27-7b8b-42cf-89c0-62ad002221cc
Dodek, P.
ee29f74b-3884-4c96-9980-c7b0b377fafd
Heels-Ansdell, D.
364ac741-2508-44ca-875a-26fa5b7f5833
Meade, M.
157e7055-92ac-4c89-ab51-3e9039b0d904
Pemberton, J.
91d4d2f9-901b-4fe6-bbf1-a303d9032828
Skrobik, Y.
68cf8f4a-0336-4c99-86c7-b62363c2f82d
Seppelt, I.
27d38f50-c9fc-4d5c-bec1-45e69b6d3604
Vlahakis, N.E.
371da7ba-1ea8-48b7-ae16-5d63dd04b05a
Muscedere, J.
949ec41b-09d5-4b1a-9a9f-b726c8ff530b
Reece, G.
27d44934-027f-406b-bbf2-841483f085ec
Ostermann, M.
3aad45dd-7d86-40cf-80ee-d6401ebdace2
Padayachee, S.
44487cf9-1d7b-4fe1-a69c-177d1e29ceea
Alhashemi, J.
56fd0c9f-1d57-43c7-9237-75879f17fee3
Walsh, M.
af03f6c9-6790-4d20-b1eb-7e89eb7f8d13
Lewis, B.
e6341bc4-ae2e-4678-8cf8-f1237f740cf9
Schiff, D.
74d7510e-affe-4fea-b4a8-83da6b6eced5
Moody, A.
92e46e31-f39f-45cc-9f83-d13fb1de620a
Zytaruk, N.
ff2a88e5-6d8f-4c40-b42c-3b599903b604
LeBlanc, M.
ac6c8255-f84b-4408-8f4a-66c26e395019
Cook, D.J.
611a8241-6755-4977-956a-cabbff5373d3
Lesur, O.
962c34f7-d58f-46da-8018-e958dcfd4c83
Proulx, S.
2b5af2a1-1f08-445b-a255-dbbed0c9150f
Cloutier, S.
0b87abd8-6944-4d9c-aaf4-4b2b82947740
Bolduc, B.
20ec53e4-73fb-4f50-a8cc-235ddcbe3951
Rousseau, M.-P.
7064e98c-f7e4-4182-b46a-db5863a8252e
Leblond, J.
62ab95bb-5f7b-4300-96b1-314d9e7dd599
Schmutz, G.
5843bc75-938d-4aba-88f7-c4b6d4fb4b18
Hebert, P.
db06cda1-bea6-4a97-8cd7-52db87b22a6f
Watpool, I.
72327c18-076d-4412-92cd-b82f17e909e4
McArdle, T.
bd4294df-f458-4de1-aa86-b5986f8da16c
Gaudert, C.
28df7bc6-28e3-47fe-b0ca-574511566754
Marchand, P.
5c97eec8-1089-49cb-b825-875de03af64b
Davidson, C.
1d26c907-6221-4335-9c15-acd5862bf0d8
Dugal, A.-M.
1051086f-4a13-47a6-bf64-96c1b6d1038d
Fetzer, S.
6979fca9-4ca5-4c81-8c9f-7de10fc71eef
Shabana, W.
134eb791-7f69-403a-9197-2234f4cea515
Castonguay, M.
f83c0983-7ea9-476f-8660-4682eea05744
Anwar, S.
0c78bee7-b0f4-4e55-874e-68543690362a
Kozarenko, V.
19365d3a-d435-4a40-abf3-7bc50e5b5c2b
Mohammad, S.
641b37f7-4100-471d-8c34-c600299520a7
Sikalska, S.
f761834d-2bd8-4239-95e5-d7b7a2fba02f
Gauthier, S.
1b315d1d-07f0-4ac4-9658-0740bcd7fc19
Mustafa, A.
f362a6d6-291f-477c-9e5c-78fc879693ed
Ashley, B.J.
83b23372-4fee-4bdb-b0da-c3e72565138f
Mans, S.
9ee436d2-45b3-457f-ae11-9f13a4e99a36
Pavan, M.
f4896fdf-4860-4e5a-b066-6dd98bd427d9
Leipsic, J.
24a7559b-a517-44e5-8b39-157ade85f8b3
Meiersdorf, S.
112a83bd-c87d-411c-8a6e-118a3baca378
McKenzie, C.
ec344dee-5777-49c5-970e-6326e82c9f8c